Methylamino-pterin derivative with inhibiting nitric oxide synthetase function
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2008-05-28
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a new class of MTX derivatives, and specifically relates to a methotrexate derivative with the effect of inhibiting nitric oxide synthase, which can improve the anti-tumor and anti-articular effects of the clinical drug MTX (methotrexate) Inflammation, treatment of intestinal diseases, as the activity of family planning, etc. Background technique
[0002] (1) Biochemical and pharmacological effects of MTX and its application
[0003] Tetrahydrofolates (abbreviated as THF) derivatives are extremely important substrates for various enzymes of one-carbon metabolism in cells, that is, donors of formyl, hydroxymethyl or methyl in pyrimidine and purine biosynthesis , plays an important role in the processes of DNA and RNA synthesis, replication and repair. The synthesis of tetrahydrofolate in cells is completed by folic acid through the action of dihydrofolate reductase (Dihydrofolate reductase, DHFR). Folic acid and metho...